Medicare Part D coverage · BX Rating · RxCUI 2001564
BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet
Per the CMS 2026 Part D formulary file, BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet is covered by 1,173 Medicare Part D plans (23.2% of enrollable products), averaging Tier 2.7, with prior authorization required on 3.5% of covering formularies.
- 23.2%
- Plan coverage
- 1,173
- Plans covering
- T2.7
- Avg tier
- 3.5%
- Prior auth required
What the CMS Formulary Data Shows for BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet
Per the CMS 2026 Part D formulary file, BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet (RxNorm concept RXCUI 2001564, generic name BX Rating) appears on 57 distinct formulary files spanning 1,173 Medicare Part D plan offerings - 23.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.7.
Real-world access to BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet depends on utilization management as much as tier placement: 3.5% of covering formularies require prior authorization. 0% require step therapy. 80.7% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet today.
Coverage Details
- Formularies covering
- 57
- Plans covering
- 1,173
- Coverage rate
- 23.2%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 3.5% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 80.7% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T1 | No | $0 | CA |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | No | $0 | CA |
| PHP (HMO C-snp) | Aids Healthcare Foundation | T1 | No | $0 | CA |
| VNS Health Total (HMO D-SNP) | VNS Choice | T1 | No | $0 | NY |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T1 | Yes | $0 | CA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | No | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | No | $0 | DE |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | No | $4.80 | FL |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $13.10 | PA |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Arizona | T1 | No | $17.00 | AZ |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $17.60 | PA |
Show the next 30 plans
| Highmark Health Options Duals Select (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | No | $31.20 | DE |
| VNS Health EasyCare Plus (HMO D-SNP) | VNS Choice | T1 | No | $51.60 | NY |
| Network Health Select (PPO) | Network Health Insurance Corporation | T2 | No | $0 | WI |
| Network Health Go (PPO) | Network Health Insurance Corporation | T2 | No | $0 | WI |
| Network Health Anywhere (PPO) | Network Health Insurance Corporation | T2 | No | $0 | WI |
| Network Health Choice (PPO) | Network Health Insurance Corporation | T2 | No | $0 | WI |
| Network Health Zero (PPO) | Network Health Insurance Corporation | T2 | No | $0 | WI |
| Troy Medicare (HMO) | Troy Health, Inc. | T2 | No | $0 | NC |
| Troy Medicare for Dual-eligible Beneficiaries (HMO D-SNP) | Troy Health, Inc. | T2 | No | $0 | NC |
| Contra Costa Health Care Plus (HMO D-SNP) | Contra Costa County Medical Service DBA Contra Costa Health | T2 | No | $0 | CA |
| Keystone First VIP Choice (HMO D-SNP) | Vista Health Plan, Inc. | T2 | No | $0 | PA |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Vista Health Plan, Inc. | T2 | No | $0 | PA |
| First Choice VIP Care (HMO D-SNP) | Select Health OF South Carolina, Inc. | T2 | No | $0 | SC |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | AmeriHealth Caritas VIP Next, Inc. | T2 | No | $0 | DE |
| AmeriHealth Caritas VIP Care Choice (HMO D-SNP) | AmeriHealth Caritas VIP Next, Inc. | T2 | No | $0 | DE |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Caritas Florida, Inc. | T2 | No | $0 | FL |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Caritas Louisiana, Inc. | T2 | No | $0 | LA |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Caritas North Carolina, Inc. | T2 | No | $0 | NC |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Michigan, Inc. | T2 | No | $0 | MI |
| Healthy Mississippi Premier Advantage (HMO-POS) | Healthy Mississippi, Inc. | T2 | No | $0 | MS |
| Wellcare Superior HealthPlan Dual Align (HMO D-SNP) | Superior Healthplan, Inc. | T2 | No | $0 | TX |
| Wellcare Superior HealthPlan Dual Align (HMO D-SNP) | Superior Healthplan, Inc. | T2 | No | $0 | TX |
| Wellcare Dual Access Open (PPO D-SNP) | Wellcare OF Mississippi, Inc. | T2 | No | $0 | MS |
| Wellcare Dual Access Open (PPO D-SNP) | Wellcare OF Georgia, Inc. | T2 | No | $0 | GA |
| Wellcare Dual Liberty Sync (HMO D-SNP) | Wellcare OF Texas, Inc. | T2 | No | $0 | TX |
| Wellcare Dual Liberty Sync (HMO D-SNP) | Wellcare OF Texas, Inc. | T2 | No | $0 | TX |
| Wellcare Dual Liberty (HMO D-SNP) | Wellcare OF Connecticut, Inc. | T2 | No | $0 | CT |
| Wellcare Dual Liberty (HMO-POS D-SNP) | Buckeye Community Health Plan, Inc. | T2 | No | $0 | OH |
| Wellcare Fidelis Dual Align (HMO D-SNP) | Wellcare Health Plans OF NEW Jersey, Inc. | T2 | No | $0 | NJ |
| Wellcare Sunshine Health Dual Align (HMO D-SNP) | Sunshine State Health Plan, Inc. | T2 | No | $0 | FL |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet covered by Medicare Part D?
Yes, BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet is covered by 1,173 Medicare Part D plans (23.2% of all Part D formularies).
What tier is BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet on Medicare Part D plans?
BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet averages Tier 2.7 across Part D plans, ranging from Tier 1 to Tier 4.
Does BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet require prior authorization?
3.5% of Part D formularies require prior authorization for BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet. Step therapy: 0%. Quantity limits: 80.7%.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 3 ML insulin aspart, human 100 UNT/ML Cartridge [NovoLog] T2.7
- aliskiren 150 MG Oral Tablet T2.7
- cyclosporine, modified 100 MG Oral Capsule T2.7
- Niacinamide insulin aspart, human 100 UNT/ML Injectable Solution [Fiasp] T2.7
- tazarotene 1 MG/ML Topical Cream T2.7
- tenofovir disoproxil fumarate 300 MG Oral Tablet T2.7
Similar prior-authorization rate
- 24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 7 MG Extended Release Oral Capsule [Namzaric] 3.5% PA
- 84 HR estradiol 0.00156 MG/HR Transdermal System 3.5% PA
- 24 HR desvenlafaxine 100 MG Extended Release Oral Tablet 3.4% PA
- ethinyl estradiol 0.0025 MG / norethindrone acetate 0.5 MG Oral Tablet [Fyavolv] 3.4% PA
- insulin, regular, human 100 UNT/ML Injectable Solution [Humulin R] 3.4% PA
- 1.5 ML aripiprazole 200 MG/ML Prefilled Syringe [Abilify] 3.7% PA